Pediatric Epidemiology Fellows
jense958@umn.edu
Dr. Jensen received his Ph.D. in Pharmaceutical Science from the TJL School of Pharmacy at the University of the Pacific (Stockton, California) in 2006. During his PhD, he investigated molecular mechanisms with a focus on the ability to inhibit tumor cell signaling. As a Pediatric Cancer Epidemiology Post Doctoral Fellow, Dr. Jensen is studying the mechanisms of neurotoxicity associated with chemotherapy along with the role of SNPs in the treatment of pediatric leukemia and lymphoma. Dr. Jensen is also pursuing a MS in Clinical Research from the School of Public Health.
char0175@umn.edu
Dr. Charbonneau received a PhD in microbiology from the University of Iowa in 2007. Her research focus was on the role of regulatory T cells in the control of prostate inflammation in an animal model. Dr. Charbonneau is interested in understanding how inflammation and genetics may play a role in childhood cancer. She will be working with Dr. David Largaespada and Dr. Ross on characterizing the underlying genetic mutations associated with pediatric rhabdomyosarcoma in a mouse model. She also will be working with Drs. Brenda Weigel and Simona Ognjanovic on human studies of rhabdomyosarcoma. Dr. Charbonneau plans to enroll in the MPH program in Epidemiology.
john5713@umn.edu
Dr. Johnson received her PhD in Epidemiology from the University of Minnesota in November, 2007. Her pediatric cancer research interests center around exposures that occur during the perigestational period (in and around pregnancy). Her graduate work focused on the relation between childhood cancer and perigestational exposure to radiation, folic acid, and factors recorded in birth records. She is particularly interested in combining her laboratory experience in the basic sciences with her epidemiology training to advance understanding of the pediatric cancer etiology. To that end, part of her post-doctoral work in addition to traditional epidemiological studies, will use a mouse model to understand how folic acid intake during pregnancy could impact cancer risk in the offspring.
Amy Linabery, M.P.H., M.S.
devr0053@umn.edu
Ms. Linabery's primary area of research interest involves furthering the scientific understanding of cancer etiology, with an emphasis on examining gene-environment interactions. Specifically, her research will focus on pediatric oncology, as the etiology of many childhood malignancies is not well understood. Additionally, she is interested in the development of epidemiologic study methodologies, such as study design and exposure assessment.
